Science Explorer Back to mapMap
Discussion
Company · Lawrence · United States

CritiTech (United States)

crititech.comROR OpenAlex
Research works
5
▲ 26% vs 2018-21
Citations
44
9.2 per fractional work
Top-10% rate
2.7%
all institutions 10.0%
Open access
56%
world 40%
International
4%
world 18%
CritiTech (United States)

Not ranked overall: CritiTech (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does CritiTech (United States) work in?

In all years, 53% of research at CritiTech (United States) is in Health Sciences, 36% in Life Sciences. Its largest fields are Medicine (47%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (9%). It does 1.3× the world's share of Health Sciences.

Health Sciences: 2 fractional works · 53.2% of its workMedicine: 2 fractional works · 46.8% of its workHealth Professions: 0 fractional works · 4.3% of its workVeterinary: 0 fractional works · 2.1% of its workLife Sciences: 2 fractional works · 36.2% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 21.3% of its workImmunology and Microbiology: 0 fractional works · 8.5% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 4.3% of its workAgricultural and Biological Sciences: 0 fractional works · 2.1% of its workPhysical Sciences: 0 fractional works · 10.6% of its workMaterials Science: 0 fractional works · 6.4% of its workEngineering: 0 fractional works · 4.3% of its workALL ITS WORKCritiTech (UnitedStates)5fractional works, all years
Life Sciences36%Physical Sciences11%Health Sciences53%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 9 fields, with their numbers
    1. Medicine246.8%
    2. Health Professions04.3%
    3. Veterinary02.1%
    1. Biochemistry, Genetics and Molecular Biology121.3%
    2. Immunology and Microbiology08.5%
    3. Pharmacology, Toxicology and Pharmaceutics04.3%
    4. Agricultural and Biological Sciences02.1%
    1. Materials Science06.4%
    2. Engineering04.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.60× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.93× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 22.71× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 21.62× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.82× its world share, 0 worksChemistryMaterials Science: 2.18× its world share, 0 worksMaterials ScienceMedicine: 1.59× its world share, 0 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 22.7×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Immunology and Microbiology22.71×0 works
  2. Pharmacology, Toxicology and Pharmaceutics21.62×0 works
  3. Biochemistry, Genetics and Molecular Biology3.93×0 works
  4. Materials Science2.18×0 works
  5. Chemistry1.82×0 works
  6. Agricultural and Biological Sciences1.60×0 works
  7. Medicine1.59×0 works

What are the most cited papers from CritiTech (United States)?

The most cited paper from CritiTech (United States) is "A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies" (Stephen K. Williamson, Gary Alan Johnson, Holly A. Maulhardt et al., 2015), with 69 citations. Next come "Pharmacokinetic Profile of Inhaled Submicron Particle Paclitaxel (NanoPac ® ) in a Rodent Model" (24) and "Local administration of submicron particle paclitaxel to solid carcinomas induces direct cytotoxicity and immune-mediated tumoricidal effects without local or systemic toxicity: preclinical and clinical studies" (20).

Most cited papers
#PaperReleasedCitations
1 A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies Stephen K. Williamson, Gary Alan Johnson, Holly A. Maulhardt et al. · Cancer Chemotherapy and Pharmacology Open access 22 Apr 2015 69
2 Pharmacokinetic Profile of Inhaled Submicron Particle Paclitaxel (NanoPac ® ) in a Rodent Model James Verco, William Forrest Johnston, Michael Jay Baltezor et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery Open access 25 Oct 2018 24
3 Local administration of submicron particle paclitaxel to solid carcinomas induces direct cytotoxicity and immune-mediated tumoricidal effects without local or systemic toxicity: preclinical and clinical studies Shelagh J. Verco, Holly A. Maulhardt, Michael Jay Baltezor et al. · Drug Delivery and Translational Research Open access 6 Nov 2020 20
4 Inhaled Submicron Particle Paclitaxel (NanoPac) Induces Tumor Regression and Immune Cell Infiltration in an Orthotopic Athymic Nude Rat Model of Non-Small Cell Lung Cancer James Verco, William Forrest Johnston, Michael Frost et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery Open access 26 Jul 2019 15
5 Phase I dose escalation safety study of nanoparticulate paclitaxel (CTI 52010) in normal dogs Sandra M. Axiak‐Bechtel, Selting, Decedue et al. · International Journal of Nanomedicine Open access Oct 2011 15
All 13 most cited papers, with filters and sorting

Which research topics does CritiTech (United States) publish most on?

By volume in 2022-now: Immunotherapy and Immune Responses, Inhalation and Respiratory Drug Delivery, Nanoparticle-Based Drug Delivery and Immune cells in cancer.

Immunotherapy and Immune Responses: 0 fractional worksInhalation and Respiratory Drug Delivery: 0 fractional worksNanoparticle-Based Drug Delivery: 0 fractional worksImmune cells in cancer: 0 fractional worksAsthma and respiratory d…0Asthma and respiratory diseases: 0 fractional worksRNA Interference and Gene Delivery: 0 fractional worksIon channel regulation and function: 0 fractional worksAdvanced Drug Delivery S…0Advanced Drug Delivery Systems: 0 fractional worksMicroencapsulation and Drying Processes: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional works
ImmunologyPulmonary and Respiratory MedicineBiomaterialsPhysiology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immunotherapy and Immune Responses Immunology 0 works
  2. 2 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works
  3. 3 Nanoparticle-Based Drug Delivery Biomaterials 0 works
  4. 4 Immune cells in cancer Immunology 0 works
  5. 5 Asthma and respiratory diseases Physiology 0 works
  6. 6 RNA Interference and Gene Delivery Molecular Biology 0 works
  7. 7 Ion channel regulation and function Molecular Biology 0 works
  8. 8 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
  9. 9 Microencapsulation and Drying Processes Food Science 0 works
  10. 10 Cancer Immunotherapy and Biomarkers Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available55.7%not open44.3%

World: 40% of research is openly available.

with international co-authors3.5%domestic only96.5%

World: 18% is written across borders.

How has CritiTech (United States)'s research output changed?

Output in 2022-2025 was 26% higher than in 2018-2021.

201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is CritiTech (United States) as a percentage of every work published that year, 0.0000024% in 2023.

0.000010%0.000020%0.000030%CritiTech (United States)0.000012% in 202420102020

Fractional works of CritiTech (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lawrence

All research institutions in Lawrence

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about CritiTech (United States). Posts are plain text and can be reported.